WEST LAFAYETTE, IN, February 22, 2022 — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), is pleased to announce that Mo Dastagir has joined the Company as Chief Technology Officer as we continue to invest in technology innovation and infrastructure to improve and support our evolving business.

Dastagir comes to Inotiv with high-energy and a passion for how the application of information technology enables more rewarding experiences for our clients and employees. His key responsibilities will include:

Mo Dastagir, Chief Technology Officer

• 🔸Developing an industry-leading digital strategy for Inotiv
• 🔸Creating a strategic data analytics and insights platform
• 🔸Architect and building a scalable technology platform to enable rapid organic and inorganic growth
• 🔸Leading and overseeing global Technology operations
• 🔸Implementing a state-of-the-art Cyber Security program
• 🔸Strategizing and creating solutions specific to Inotiv’s unique needs that improve quality, accelerate speed to market and drive profitability
• 🔸Developing the technology strategy, in partnership with executive leadership, to drive growth across the company

“We are so pleased to have Mo join the Inotiv team,” said President and CEO, Robert Leasure, Jr. “We believe his leadership and experience will strengthen our team, enable growth for our business, and create an environment of collaboration and innovation to drive our company to new heights.”

Dastagir has deep knowledge of the life sciences industry, having worked for both Roche and Novartis, as well as a range of other industries including Amazon, Sears, and most recently, Cresco Labs.

“It’s an honor to join Inotiv and be part of its highly talented leadership team,” said Dastagir. “In the past few years, the company has made great strides in positioning itself to be the CRO of choice in the DSA and RMS space. I look forward to working closely with our clients and with the Inotiv leadership team to develop and execute our digital strategy.”

Dastagir earned his bachelor’s degree in Business from India’s Osmania University and holds a Master of Business Administration degree in International Business degree from the Institute of Chartered Financial Analysts of India. He also serves on a few advisory boards to assist young companies in accelerating forward.

On a personal note, Dastagir is passionate about social equity and equality causes, such as diversity in the workforce, fair pay for all genders and backgrounds, improving tech education in underrepresented communities, eradicating world hunger and improving the global housing crisis.

About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotivco.com/.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.